Truist Financial Corp has sold 798 shares of
Teleflex Incorporated (NYSE:TFX), while
Natixis Advisors L.P. acquired 23,630 shares. The company's
CEO compensation has been deemed fair, even though shareholders who invested three years ago are in the red. Despite some operational hiccups, Teleflex is still considered a compelling investment, delivering solid shareholder returns despite its five-year earnings growth trailing. The company has plans for a $0.34 quarterly dividend and revealed its Q1 2024 financial results, which included steady growth and a full-year outlook. However, their Q1 Earnings and revenues surpassed estimates, despite the stock underperforming in some trading days. They've made significant moves such as the limited release of their new
Wattson™ Temporary Pacing Guidewire and the debut of their
Unified UroLift 2 System with ATC, and completed the acquisition of
Palette Life Sciences to boost their urology portfolio. Their growth drivers have been questioned, predicting potential business realignment.
Teleflex Incorporated TFX News Analytics from Tue, 29 Oct 2013 07:00:00 GMT to Fri, 10 May 2024 09:37:13 GMT -
Rating 7
- Innovation 2
- Information 4
- Rumor -1
